益生菌市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

2024 年全球益生菌市场价值为 721 亿美元，预计到 2034 年将以 8.5% 的复合年增长率增长至 1,651 亿美元。

益生菌是活的微生物，适量摄取后可带来多种健康益处。消费者对肠道健康、免疫系统支持和整体健康的日益重视，推动了全球对益生菌产品的需求。永续发展趋势也进一步促进了市场成长，製造商致力于使用环保原材料和生产系统，以减少对有限自然资源的依赖。製造基础设施的进步使企业能够提高效率并最大限度地减少对环境的影响，从而有助于产业的长期永续发展。生产设施的现代化也降低了营运成本，并支持了配方和包装方面的持续创新。这些发展与全球永续发展目标一致，同时也鼓励对下一代益生菌生产技术进行投资。北美目前在益生菌市场占据领先地位，这得益于其完善的监管框架和强大的生产能力。同时，亚太地区正在崛起成为成长最快的市场，这主要得益于消费者健康意识的提高、快速的城市化进程以及对创新益生菌菌株开发和输送系统的大规模投资。

2024年，细菌益生菌市场规模达640亿美元。该市场涵盖多种菌属，包括乳桿菌属、双歧桿菌属、链球菌属以及阿克曼菌属和粪桿菌属等新兴菌株。儘管传统乳桿菌属曾一度主导市场，但随着科学分类的不断深入，益生菌的分类范围已扩展至包括乳酸桿菌属、植物乳桿菌属和乳酸桿菌属等。这些细菌经临床验证，对消化系统健康、免疫功能和代谢平衡都有益处。其长期以来获得监管机构的认可，并拥有持续的临床证据，这些证据都进一步巩固了它们作为健康和保健领域重要益生菌菌株的市场地位。

2024年，人类膳食补充剂市占率将达到44.7%，主要得益于消费者对便利高效益生菌产品的偏好。胶囊、粉末、药片和液体补充剂因其服用方便且能提供针对性的健康益处，越来越受到消费者青睐，成为日常保健的首选。日益增强的健康意识，以及老年人口不断增长导致消化系统疾病的增加，持续推动着这个细分市场的成长。益生菌在消化和免疫健康方面作用的科学验证不断深入，进一步巩固了其在日常健康生活方式中的应用。随着消费者寻求天然益生菌来源，包括优格、发酵饮料和其他富含益生菌的食品在内的功能性食品和饮料应用也在迅速扩张。

预计2025年至2034年间，北美益生菌市场将以8.6%的复合年增长率成长。该地区的成长主要归功于消费者对肠道健康与免疫力之间关联的认识不断提高，以及益生菌在膳食补充剂和功能性食品中的应用日益广泛。菌株研发的持续创新和递送技术的改进提升了产品的稳定性、功效和保质期。这些进步使製造商能够开发出适用于饮料、零食和药品等多种应用的益生菌产品，从而促进区域市场的普及和竞争力。

全球益生菌市场的主要参与者包括 Lallemand、达能集团 (Danone SA)、ADM、雀巢 (Nestle)、Kerry Group、Sabinsa Corporation、Kaneka Probiotics、森永营养食品株式会社 (Morinaga Nutritional Foods, Inc.)、Sanzyme Biologics、Novonesis、Prorance AB 和国际香料公司 (International Fir)。益生菌市场的领导企业正积极推行策略倡议，以提升其全球市场地位和品牌知名度。雀巢、ADM 和达能集团等公司正大力投资研发，以开发具有临床疗效的新型益生菌菌株。策略合作和收购正被用于拓展分销网络并强化产品组合。许多企业正致力于微胶囊化和发酵技术的进步，以提高益生菌的稳定性和递送效率。

目录

第一章：方法论与范围

第二章：执行概要

第三章：行业洞察

• 产业生态系分析
  • 供应商格局
  • 利润率
  • 每个阶段的价值增加
  • 影响价值链的因素
  • 中断
• 产业影响因素
  • 成长驱动因素
    • 消费者健康意识的提高和预防性医疗保健的普及
    • 消化系统疾病和抗生素抗药性问题日益严重
    • 在功能性食品和个人化营养领域的应用不断拓展
  • 产业陷阱与挑战
    • 生产和储存中的可行性和稳定性挑战
    • 生产规模化和持续品质保证
  • 市场机会
    • 心理健康与肠脑轴领域的新兴应用
    • 基于微生物组分析的个人化益生菌
• 成长潜力分析
• 监管环境
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东和非洲
• 波特的分析
• PESTEL 分析
• 技术与创新格局
  • 当前技术趋势
  • 新兴技术
• 价格趋势
  • 按地区
  • 副产品
• 未来市场趋势
• 专利格局
• 贸易统计（HS编码）（註：仅提供重点国家的贸易统计资料）
  • 主要进口国
  • 主要出口国
• 永续性和环境方面
  • 永续实践
  • 减少废弃物策略
  • 生产中的能源效率
  • 环保倡议
• 碳足迹考量

第四章：竞争格局

• 介绍
• 公司市占率分析
  • 按地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • MEA
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 关键进展
  • 併购
  • 合作伙伴关係与合作
  • 新产品发布
  • 扩张计划

第五章：市场估算与预测：依成分划分，2021-2034年

• 主要趋势
• 细菌益生菌
  • 乳酸桿菌
  • 双歧桿菌
  • 芽孢桿菌
  • 其他的
• 酵母益生菌
  • 布拉氏酵母
  • 酿酒酵母
  • 其他的

第六章：市场估算与预测：依应用领域划分，2021-2034年

• 主要趋势
• 人类膳食补充剂
  • 胶囊和片剂
  • 粉末和液体补充剂
  • 软糖和咀嚼片
• 功能性食品和饮料
  • 乳製品益生菌产品
  • 优格和发酵乳
  • 乳酪和乳製品
  • 植物基和非乳製品替代品
  • 益生菌饮料和功能饮料
  • 强化食品的应用
  • 早餐麦片和营养棒
  • 烘焙食品和糖果
  • 冷冻和加工食品
• 动物营养与饲料应用
  • 牲畜饲料添加剂
  • 家禽
  • 伴侣动物
• 药品和医疗产品
  • 活体生物治疗产品
  • 处方益生菌药物
  • 特殊医学食品与临床营养
• 其他的

第七章：市场估算与预测：依最终用途产业划分，2021-2034年

• 主要趋势
• 食品饮料製造
  • 乳製品加工
  • 功能性食品製造商
  • 有机天然产品
• 製药与生物技术
• 动物农业和饲料
• 消费者健康与保健
• 其他的

第八章：市场估算与预测：依地区划分，2021-2034年

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第九章：公司简介

• ADM
• Novonesis
• Danone SA
• International Flavors & Fragrances
• Kaneka Probiotics
• Kerry Group
• Lallemand
• Morinaga Nutritional Foods, Inc.
• Nestle
• Probi AB
• Sabinsa Corporation
• Sanzyme Biologics

The Global Probiotics Market was valued at USD 72.1 billion in 2024 and is estimated to grow at a CAGR of 8.5% to reach USD 165.1 billion by 2034.

Probiotics are live microorganisms that, when consumed in appropriate amounts, deliver various health benefits. Growing consumer understanding of gut health, immune system support, and overall wellness has fueled the global demand for probiotic products. The market's growth is further influenced by sustainability trends, as manufacturers focus on eco-friendly raw materials and production systems that reduce dependence on finite natural resources. Advancements in manufacturing infrastructure have enabled companies to improve efficiency and minimize environmental impact, contributing to long-term industry sustainability. The modernization of production facilities has also reduced operational costs and supported continuous innovation in formulation and packaging. These developments align with global sustainability goals while encouraging investment in next-generation probiotic production technologies. North America currently leads the probiotics market, supported by strong regulatory frameworks and robust manufacturing capabilities. Meanwhile, the Asia-Pacific region is emerging as the fastest-growing market, driven by increasing consumer health awareness, rapid urbanization, and large-scale investment in innovative probiotic strain development and delivery systems.

The bacterial probiotics segment generated USD 64 billion in 2024. This segment consists of multiple genera, including Lactobacillus, Bifidobacterium, Streptococcus, and emerging strains such as Akkermansia and Faecalibacterium. Although the market was once dominated by traditional lactobacillus species, scientific reclassifications have diversified the taxonomy to include genera such as lacticaseibacillus, lactiplantibacillus, and limosilactobacillus. These bacteria are clinically validated for their contributions to digestive health, immune function, and metabolic balance. Their long-standing regulatory acceptance and consistent clinical evidence continue to strengthen their market position as essential probiotic strains in the health and wellness sector.

The human dietary supplements segment held 44.7% share in 2024, owing to the preference for convenient and concentrated probiotic formats. Consumers increasingly favor capsules, powders, tablets, and liquid supplements for daily use, as they offer ease of consumption and targeted health benefits. Rising health consciousness, coupled with the growing elderly population experiencing digestive disorders, continues to fuel this segment's growth. The ongoing scientific validation of probiotics' role in digestive and immune health has strengthened their integration into daily wellness routines. Functional food and beverage applications, including yogurts, cultured drinks, and other probiotic-enriched foods, are also expanding rapidly as consumers seek natural dietary sources for probiotics.

North America Probiotics Market is expected to grow at a CAGR of 8.6% between 2025 and 2034. Growth across the region is primarily attributed to heightened consumer awareness about the link between gut health and immunity, coupled with the expanding use of probiotics in dietary supplements and functional food products. Ongoing innovations in strain development and improvements in delivery technology have enhanced product stability, effectiveness, and shelf life. These advancements allow manufacturers to create versatile probiotic products suitable for beverages, snacks, and pharmaceutical applications, thereby boosting regional market adoption and competitiveness.

Major players operating in the Global Probiotics Market include Lallemand, Danone S.A., ADM, Nestle, Kerry Group, Sabinsa Corporation, Kaneka Probiotics, Morinaga Nutritional Foods, Inc., Sanzyme Biologics, Novonesis, Probi AB, and International Flavors & Fragrances. Leading companies in the probiotics market are pursuing strategic initiatives to enhance their global market position and brand visibility. Organizations such as Nestle, ADM, and Danone S.A. are investing heavily in research and development to create novel probiotic strains with proven clinical efficacy. Strategic collaborations and acquisitions are being used to expand distribution networks and strengthen product portfolios. Many players are focusing on technological advancements in microencapsulation and fermentation to enhance probiotic stability and delivery efficiency.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Ingredient trends
  • 2.2.2 Application trends
  • 2.2.3 End use industry trends
  • 2.2.4 Regional trends
• 2.3 TAM Analysis, 2025-2034
• 2.4 CXO perspectives: strategic imperatives
  • 2.4.1 Executive decision points
  • 2.4.2 Critical success factors
• 2.5 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Supplier landscape
  • 3.1.2 Profit margin
  • 3.1.3 Value addition at each stage
  • 3.1.4 Factor affecting the value chain
  • 3.1.5 Disruptions
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising consumer health consciousness & preventive healthcare adoption
    • 3.2.1.2 Increasing digestive health disorders & antibiotic resistance concerns
    • 3.2.1.3 Expanding applications in functional foods & personalized nutrition
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Viability & stability challenges in manufacturing & storage
    • 3.2.2.2 Manufacturing scalability & consistent quality assurance
  • 3.2.3 Market opportunities
    • 3.2.3.1 Emerging applications in mental health & gut-brain axis
    • 3.2.3.2 Personalized probiotics based on microbiome analysis
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
  • 3.4.4 Latin America
  • 3.4.5 Middle East & Africa
• 3.5 Porter's analysis
• 3.6 PESTEL analysis
• 3.7 Technology and Innovation landscape
  • 3.7.1 Current technological trends
  • 3.7.2 Emerging technologies
• 3.8 Price trends
  • 3.8.1 By region
  • 3.8.2 By product
• 3.9 Future market trends
• 3.10 Patent Landscape
• 3.11 Trade statistics (HS code) ( Note: the trade statistics will be provided for key countries only)
  • 3.11.1 Major importing countries
  • 3.11.2 Major exporting countries
• 3.12 Sustainability and environmental aspects
  • 3.12.1 Sustainable practices
  • 3.12.2 Waste reduction strategies
  • 3.12.3 Energy efficiency in production
  • 3.12.4 Eco-friendly initiatives
• 3.13 Carbon footprint consideration

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
  • 4.2.1 By region
    • 4.2.1.1 North America
    • 4.2.1.2 Europe
    • 4.2.1.3 Asia Pacific
    • 4.2.1.4 LATAM
    • 4.2.1.5 MEA
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Ingredients, 2021-2034 (USD Billion) (Kilo Tons)

• 5.1 Key trends
• 5.2 Bacterial probiotics
  • 5.2.1 Lactobacillus
  • 5.2.2 Bifidobacterium
  • 5.2.3 Bacillus
  • 5.2.4 Others
• 5.3 Yeast probiotics
  • 5.3.1 Saccharomyces boulardii
  • 5.3.2 Saccharomyces cerevisiae
  • 5.3.3 Others

Chapter 6 Market Estimates and Forecast, By Application, 2021-2034 (USD Billion) (Kilo Tons)

• 6.1 Key trends
• 6.2 Human dietary supplements
  • 6.2.1 Capsule & tablet
  • 6.2.2 Powder & liquid supplement
  • 6.2.3 Gummy & chewable
• 6.3 Functional foods & beverages
  • 6.3.1 Dairy-based probiotic products
  • 6.3.2 Yogurt & fermented milk
  • 6.3.3 Cheese & dairy
  • 6.3.4 Plant-based & non-dairy alternatives
  • 6.3.5 Probiotic beverages & functional drinks
  • 6.3.6 Fortified food applications
  • 6.3.7 Breakfast cereals & nutrition bars
  • 6.3.8 Baked goods & confectionery
  • 6.3.9 Frozen & processed foods
• 6.4 Animal nutrition & feed applications
  • 6.4.1 Livestock feed additives
  • 6.4.2 Poultry
  • 6.4.3 Companion animal
• 6.5 Pharmaceutical & medical products
  • 6.5.1 Live biotherapeutic products
  • 6.5.2 Prescription probiotic medications
  • 6.5.3 Medical foods & clinical nutrition
• 6.6 Others

Chapter 7 Market Estimates and Forecast, By End Use Industry, 2021-2034 (USD Billion) (Kilo Tons)

• 7.1 Key trends
• 7.2 Food & beverage manufacturing
  • 7.2.1 Dairy processing
  • 7.2.2 Functional food manufacturers
  • 7.2.3 Organic & natural product
• 7.3 Pharmaceutical & biotechnology
• 7.4 Animal agriculture & feed
• 7.5 Consumer health & wellness
• 7.6 Others

Chapter 8 Market Estimates and Forecast, By Region, 2021-2034 (USD Billion) (Kilo Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 ADM
• 9.2 Novonesis
• 9.3 Danone S.A.
• 9.4 International Flavors & Fragrances
• 9.5 Kaneka Probiotics
• 9.6 Kerry Group
• 9.7 Lallemand
• 9.8 Morinaga Nutritional Foods, Inc.
• 9.9 Nestle
• 9.10 Probi AB
• 9.11 Sabinsa Corporation
• 9.12 Sanzyme Biologics